Theriva Biologics Inc. (TOVX) is a clinical-stage biotechnology company headquartered in Rockville, Maryland, specializing in the development of innovative biologic therapies aimed at addressing significant unmet medical needs. Leveraging its proprietary technology platforms, Theriva is committed to delivering targeted treatment solutions that improve patient outcomes across multiple therapeutic areas. With a strong pipeline of promising candidates and a seasoned management team, the company is strategically positioned to become a pivotal contributor in the rapidly advancing healthcare sector, making it an attractive opportunity for institutional investors. Show more

Location: 9605 MEDICAL CENTER DRIVE, ROCKVILLE, MD, UNITED STATES, 20850, Rockville, MD, 20850, USA | Website: https://therivabio.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

6.424M

52 Wk Range

$0.17 - $1.75

Previous Close

$0.18

Open

$0.18

Volume

851,650

Day Range

$0.18 - $0.19

Enterprise Value

1.307M

Cash

7.528M

Avg Qtr Burn

-4.319M

Insider Ownership

2.07%

Institutional Own.

2.41%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
VCN-01 (zabilugene almadenorepvec) (Oncolytic Adenovirus) Details First-Line Metastatic Pancreatic Ductal Adenocarcinoma	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VCN-01 (zabilugene almadenorepvec) Details Refractory Intraocular Retinoblastoma	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.